维普中文期刊产品整合服务
37篇 您的检索式:作者名="Robidoux A"
    题名 作者 年代 出处 被引量
1Evaluation of lapatinib as a component of neoadjuvant therapy for HER -2+ operable breast cancer: nsabp protocol B-41 显示文摘Robidoux A Tang G Rastogi P 2012J Clin Oncol302012,30,18:1
2phaseⅡneoadjuvant trial of sequential nanoparticle albumin-bound paclitaxel followed by5-fluorouracil/epirubicin/cyclophosphamide in locally advanced breast cancer显示文摘Robidoux A Buzdar AU Quinaux EA 2010Clin Breast Cancer2010,10,1:1
3Duration of tamoxifen use and the risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers显示文摘Gronwald J Robidoux A Kim-Sing C 2014Breast Cancer Res Treat2014,146,2:1
4Technetium-99m-sesta mibiprone Scintimammography to detect primary breast cancer and axillary lymph node involvement显示文摘TAILLEFER R ROBIDOUX A LAMBERST R 1995J Nucl Med1995,36,10:1
5Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast can- cer (NSABP protocol B-41): an open label, randomised phase 3 trial 显示文摘Robidoux A Tang G Rastogi P 2013Lancet Oncol2013,14,12:1
6Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open- label, randomised phase 3 trial显示文摘Robidoux A Tang G Rastogi P 2013Lancet Oncol2013,14,12:1
7Regulation of the uncoupling protein-2 gene in INS-1 beta-cells by ole-ic acid显示文摘Medvedev A V Robidoux J Bai X 2002J lAiol Chem2002,277,42:1
8Lapatinib as a component of neoadjuvant therapy for HER2 - positive operable breast cancer (NSABP protocol B -41 ) : an open - label, randomised phase 3 trial 显示文摘Robidoux A Tang G Rastogi P 2013Lancet Oncol2013,14,12:1
9Dysregulation of cytokine response in Canadian First Nations communities: is there an association with persistent organic pollutant levels? 显示文摘IMBEAULT P FINDLAY C S ROBIDOUX M A 2012PloS One2012,7,39:1
10A phase IIneoadjuvant trial of sequential nanoparticle albumin-boundpaclitaxel followed by 5 -fluorouracil / epirubicin /cyclophosphamide in locally advanced breast cancer显示文摘Robidoux A Buzdar AU Quinaux E 2010ClinBreast Cancer2010,10,1:1
11Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41 ) : an open-label, randomised phase 3 trial 显示文摘Robidoux A Tang G Rastogi P 2013Lancet Oncol2013,14,12:1
12Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement显示文摘Taillefer R Robidoux A Lambert R 0,,10:1
13Rapid isocratic HPLC quantification of metallothionein-like protein as biomarkers for cadmium exposure in the earthworm Eisenia andrei显示文摘Ndayibagira A Sunahara G I Robidoux P Y 2007Soil Biol Biochem2007,39,:1
14Technetium-99m-sestamibi Prone Scintimammography to Detect Primary Breast Cancer and Axillary Lymph Node Involvement显示文摘TAILLEFER R ROBIDOUX A LAMBERT R 1995J Nucl Med1995,36,10:1
15Rapid isocratic HPLC quantification of metallothionein- like proteins as biomarkers for cadmium exposure in the earthworm Eisenia andrei显示文摘Ndayibagira A Sunahara G I Robidoux P Y 2007Soil Biol Biochem2007,39,:1
16A phase II neoadjuvant trial of sequential nanoparticle albumin-bound paclitaxel followed by 5-fluorouracil/epirubicin/cyclophosphamide in locally advanced breast cancer显示文摘Robidoux A Buzdar A U Quinaux E 0,,01:1
17^99 Tc^m-sestamibi prone scintimammography to detect primary breast and axillary lymph node involvement显示文摘Taillefer R Robidoux A Lambert R 1995J Nucl Med1995,36,10:1
18Screening for BRCAl and BRCA2 mutations among French-Canadian breast cancer cases attending anoutpatient clinic in Montreal显示文摘Ghadirian P Robidoux A Nassif E 2014Clin Genet2014,85,1:1
19Lapatinib as a component of neoadjuvant therapy for HER2 -positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial显示文摘Robidoux A Tang G Rastogi P 2013Lancet Oncol2013,14,12:1
20Rapid iso- cratic HPLC quantification of metallothionein-like proteins as biomarkers for cadmium exposure in the earthworm Eisenia andrei 显示文摘Ndayibagira A Sunahara GI Robidoux PY 2007Soil Bidogy & Biochemistry2007,39,:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费